Issues - Clinical Relevance (cont.)
Temovate (cont.)
- Differences in DPK between products may be due to issues such as:
- 18-69% of applied dose recovered in SC strips in this study may represent unabsorbed drug and questions validity of study.
-
- Spreading of the emollient cream beyond the application site diminishes amount recovered.